Option Care Health (OPCH) CEO reports RSU vesting and tax share disposals

Rhea-AI Filing Summary

Option Care Health CEO John Charles Rademacher reported a mix of share acquisitions and tax-related dispositions. On February 21, 2026, he exercised 11,087 Restricted Stock Units, each converting into one share of common stock at a stated price of $0.0000 per share.

To cover tax obligations, he reported multiple F-code tax-withholding dispositions of common stock on February 20–22, 2026 at $35.69 per share. After these transactions, his direct ownership stood at 693,702 shares of common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RADEMACHER JOHN CHARLES

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		F		10,638	D	$35.69	820,419	D
Common Stock	02/21/2026		M		11,087	A	$0	831,506	D
Common Stock	02/21/2026		F		4,956	D	$35.69	826,550	D
Common Stock	02/22/2026		F		132,848	D	$35.69	693,702	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/21/2026		M			11,087	(2)	(2)	Common Stock	11,087	$0	0	D

Explanation of Responses:

1. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

2. Fully vested

	/s/ Michael Bavaro, attorney-in-fact for Mr. Rademacher	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did OPCH CEO John Rademacher report?

John Rademacher reported exercising 11,087 Restricted Stock Units into common stock and several F-code tax-withholding dispositions of common shares at $35.69 per share across February 20–22, 2026.

How many Option Care Health (OPCH) shares does the CEO hold after these Form 4 trades?

After the reported transactions, CEO John Rademacher directly owns 693,702 shares of Option Care Health common stock, reflecting both the RSU conversion and the tax-withholding share dispositions disclosed in the Form 4.

Were the OPCH CEO’s Form 4 share disposals open-market sales?

The disposals were reported with transaction code F, described as payment of tax liability by delivering securities, indicating tax-withholding dispositions rather than open-market sales of Option Care Health common stock.

What does the RSU transaction mean for OPCH CEO John Rademacher’s holdings?

He exercised 11,087 Restricted Stock Units, each converting into one share of Option Care Health common stock at a stated price of $0.0000, increasing his direct share ownership before the tax-withholding dispositions.

At what price were the OPCH tax-withholding share dispositions reported?

The F-code tax-withholding dispositions of Option Care Health common stock were reported at a transaction price of $35.69 per share, used to satisfy tax obligations associated with equity compensation events.